Delivery Order SPE2DB24D2205-SPE2DB25FDTXE

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,525.08 firm fixed-price delivery order is for the supply of 4,565,154,428 Synthroid 137 MCG tablets, with a period of performance through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award, valued at $1,150.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 1,000 units of the medication Synthroid 100 MCG Tablet. The contract has a firm fixed price and an ultimate completion date of June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award of $6,401.30 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Synthroid 137 mcg tablets. The contract has an ultimate completion date of May 17, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,679.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award covers the delivery of Synthroid 50 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of December 5, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.01 firm fixed-price delivery order is for the supply of 4,567,490,367 units of Synthroid 75 MCG tablet, a medication used to treat hypothyroidism. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $95,267.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order for the supply of Synthroid 137 MCG tablets, a medication used to treat hypothyroidism. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for $32,236.00 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp. The award covers the delivery of Synthroid 137 MCG tablets in quantities of 1,000. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.01, is a Firm Fixed Price Delivery Order for the supply of 4,567,422,798 units of the prescription drug Synthroid (88 mcg tablet). The contract has an ultimate completion date of March 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,795,652 Synthroid 50 MCG tablets. The $1,049.64 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) Troop Support Medical under their $999,999,999.00 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense (DoD) facilities worldwide. Amerisourcebergen, a large...
This federal contract award, valued at $2,078.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 88 MCG tablets in quantities of 1,000. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTXE
    Delivery Order

This federal contract award, valued at $22,011.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,384,098 units of Synthroid 137 MCG Tablet 1000s, with a completion date of November 12, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 2:01 PM